SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-018937
Filing Date
2021-08-06
Accepted
2021-08-06 17:29:19
Documents
19
Period of Report
2021-08-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.02: Unregistered Sales of Equity Securities
Item 4.01: Changes in Registrant's Certifying Accountant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 118857
2 ex10-1.htm EX-10.1 146897
3 ex10-2.htm EX-10.2 137073
4 ex10-3.htm EX-10.3 147430
5 ex10-4.htm EX-10.4 65821
6 ex10-5.htm EX-10.5 100319
7 ex10-7.htm EX-10.7 25032
8 ex99-1.htm EX-99.1 23954
  Complete submission text file 0001493152-21-018937.txt   1075274

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE indp-20210803.xsd EX-101.SCH 3021
10 XBRL LABEL FILE indp-20210803_lab.xml EX-101.LAB 34239
11 XBRL PRESENTATION FILE indp-20210803_pre.xml EX-101.PRE 22356
12 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3536
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 347-480-9760
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40652 | Film No.: 211153963
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences